var data={"title":"Overview of vitamin K","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Overview of vitamin K</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/contributors\" class=\"contributor contributor_credentials\">Sassan Pazirandeh, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/contributors\" class=\"contributor contributor_credentials\">David L Burns, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/contributors\" class=\"contributor contributor_credentials\">David Seres, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/contributors\" class=\"contributor contributor_credentials\">Kathleen J Motil, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/contributors\" class=\"contributor contributor_credentials\">Alison G Hoppin, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Apr 13, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamins are a number of chemically unrelated families of organic substances that cannot be synthesized by humans but need to be ingested in the diet in small quantities to prevent disorders of metabolism. They are divided into water-soluble and fat-soluble vitamins (<a href=\"image.htm?imageKey=PEDS%2F63827\" class=\"graphic graphic_table graphicRef63827 \">table 1</a>).</p><p>More than 50 years ago, Henrik Dam of Denmark discovered an &quot;antihemorrhagic factor&quot; that was capable of reversing dietary-induced bleeding disorders in chicks [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/1\" class=\"abstract_t\">1</a>]. The name &quot;K&quot; comes from the <span class=\"nowrap\">German/Danish</span> word koagulationsvitamin (clotting vitamin) [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/2\" class=\"abstract_t\">2</a>].</p><p>In 1930, vitamin K was first isolated by Doisy and his colleagues, as well as by Dam, from alfalfa sprouts [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/3\" class=\"abstract_t\">3</a>]. Until the 1980s, when chromatographic techniques were used, the mainstay of vitamin K isolation was through using chick bioassay [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/2\" class=\"abstract_t\">2</a>].</p><p>This topic review will focus on vitamin K. Overviews of the other fat-soluble vitamins, minerals and water-soluble vitamins are available elsewhere. (See <a href=\"topic.htm?path=overview-of-vitamin-a\" class=\"medical medical_review\">&quot;Overview of vitamin A&quot;</a> and <a href=\"topic.htm?path=overview-of-vitamin-d\" class=\"medical medical_review\">&quot;Overview of vitamin D&quot;</a> and <a href=\"topic.htm?path=overview-of-vitamin-e\" class=\"medical medical_review\">&quot;Overview of vitamin E&quot;</a> and <a href=\"topic.htm?path=overview-of-dietary-trace-minerals\" class=\"medical medical_review\">&quot;Overview of dietary trace minerals&quot;</a> and <a href=\"topic.htm?path=overview-of-water-soluble-vitamins\" class=\"medical medical_review\">&quot;Overview of water-soluble vitamins&quot;</a> and <a href=\"topic.htm?path=vitamin-supplementation-in-disease-prevention\" class=\"medical medical_review\">&quot;Vitamin supplementation in disease prevention&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">SOURCES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dietary vitamin K1 (phylloquinone or phytonadione) is found in green vegetables like spinach and broccoli (<a href=\"image.htm?imageKey=HEME%2F78708\" class=\"graphic graphic_table graphicRef78708 \">table 2</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/4\" class=\"abstract_t\">4</a>]. Gut micro-flora synthesizes vitamin K2 (menaquinones, including menatetrenone), which provides a portion of the dietary requirement of vitamin K&nbsp;[<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/4\" class=\"abstract_t\">4</a>]. Vitamin K2 has approximately 60 percent of the activity of vitamin K1, by weight, but bioavailability of both forms varies substantially depending on other intraluminal nutrients [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/5\" class=\"abstract_t\">5</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CHEMISTRY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamin K and its derivatives contain a 2-methyl-1, 4, naphthoquinone nucleus with a lipophilic side chain (<a href=\"image.htm?imageKey=HEME%2F66755\" class=\"graphic graphic_figure graphicRef66755 \">figure 1</a>).</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">METABOLISM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamin K absorption requires intact pancreatic and biliary function and fat absorptive mechanisms. Dietary vitamin K is protein-bound and is liberated by the proteolytic action of pancreatic enzymes in the small intestine. Bile salts then solubilize vitamin K into micelles for absorption into enterocytes, where it is incorporated into chylomicrons, thereby facilitating absorption into the intestinal lymphatics and portal circulation for transport to the liver [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">ACTIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamin K has a major role in coagulation pathways because it is a cofactor required for the activity of several key proteins containing carboxyglutamic acid residues. Several other proteins within the body (eg, osteocalcin) also contain carboxyglutamate residues and depend upon vitamin K for their activity (<a href=\"image.htm?imageKey=HEME%2F60052\" class=\"graphic graphic_table graphicRef60052 \">table 3</a>). (See <a href=\"topic.htm?path=vitamin-k-and-the-synthesis-and-function-of-gamma-carboxyglutamic-acid\" class=\"medical medical_review\">&quot;Vitamin K and the synthesis and function of gamma-carboxyglutamic acid&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Coagulation pathway</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamin K is essential for activity of several carboxylase enzymes within hepatic cells, and therefore is necessary for the activation of coagulation factors VII, IX, X, and prothrombin. These factors contain carboxyglutamic acid, which is carboxylated by gamma-glutamyl carboxylase, an endoplasmic enzyme found in mammalian cells (<a href=\"image.htm?imageKey=HEME%2F61632\" class=\"graphic graphic_figure graphicRef61632 \">figure 2</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/2\" class=\"abstract_t\">2</a>]. Vitamin K is the active coenzyme in this process, providing energy for the reaction through oxidation [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/7\" class=\"abstract_t\">7</a>]. After carboxylation, these proteins gain affinity for the negatively charged phospholipids on the surface of platelets and promote coagulation [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/8\" class=\"abstract_t\">8</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Antithrombotic effects of proteins C and S</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The natural anticoagulants, proteins S and C also require vitamin K for their activity. Protein C, following its activation by thrombin, inactivates factors Va and VIIIa, thus inhibiting excess generation of thrombin (see <a href=\"topic.htm?path=protein-c-deficiency#H2\" class=\"medical medical_review\">&quot;Protein C deficiency&quot;, section on 'Pathophysiology'</a>). Protein S also helps prevent excessive coagulation through its action as a cofactor for activated protein C [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/9\" class=\"abstract_t\">9</a>]. (See <a href=\"topic.htm?path=protein-s-deficiency\" class=\"medical medical_review\">&quot;Protein S deficiency&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Mechanism of action of the coumarin-like family</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Coumarin-like anticoagulants, which are similar in structure to vitamin K&nbsp;(<a href=\"image.htm?imageKey=HEME%2F66755\" class=\"graphic graphic_figure graphicRef66755 \">figure 1</a>), interrupt the vitamin K dependent carboxylation cycle by blocking reduction of the inactive vitamin K 2,3 epoxide to the active form of the vitamin (<a href=\"image.htm?imageKey=HEME%2F61632\" class=\"graphic graphic_figure graphicRef61632 \">figure 2</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/4\" class=\"abstract_t\">4</a>]. Vitamin K administration is one of the methods used to reverse the effects of coumarin. (See <a href=\"topic.htm?path=management-of-warfarin-associated-bleeding-or-supratherapeutic-inr#H6\" class=\"medical medical_review\">&quot;Management of warfarin-associated bleeding or supratherapeutic INR&quot;, section on 'Treatment'</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Bone formation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamin K is a cofactor for some proteins involved in bone mineralization, including osteocalcin (bone Gla protein) and matrix Gla protein (see <a href=\"topic.htm?path=normal-skeletal-development-and-regulation-of-bone-formation-and-resorption#H1206099\" class=\"medical medical_review\">&quot;Normal skeletal development and regulation of bone formation and resorption&quot;, section on 'Biochemistry of bone mineral matrix'</a>). Clinical trials have examined the use of vitamin K1 (phylloquinone) or vitamin K2 for the treatment of osteoporosis, with conflicting results which are discussed separately. (See <a href=\"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women#H21\" class=\"medical medical_review\">&quot;Overview of the management of osteoporosis in postmenopausal women&quot;, section on 'Therapies not recommended'</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">DEFICIENCY</span></p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Symptoms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinical signs and symptoms of vitamin K deficiency include easy bruisability, mucosal bleeding, splinter hemorrhages, melena, hematuria, or any other manifestations of impaired coagulation. Vitamin K deficiency in an otherwise healthy adult is rare. This is largely due to the wide distribution of phylloquinone in plants, menaquinone production by gut micro-flora, and because vitamin K is easily recycled within cells (<a href=\"image.htm?imageKey=HEME%2F61632\" class=\"graphic graphic_figure graphicRef61632 \">figure 2</a>). However, an acquired deficiency can occur secondary to drugs such as antibiotics. Patients on <a href=\"topic.htm?path=total-parenteral-nutrition-drug-information\" class=\"drug drug_general\">total parenteral nutrition</a> or those on long-term antibiotics are prone to develop vitamin K deficiency and require supplementation. Prolonged fasting or starvation also decreases vitamin K levels. Such patients are more sensitive to treatment with coumarin-based anticoagulants [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/10\" class=\"abstract_t\">10</a>]. (See <a href=\"#H16\" class=\"local\">'Daily value'</a> below and <a href=\"topic.htm?path=beta-lactam-antibiotics-mechanisms-of-action-and-resistance-and-adverse-effects#H18\" class=\"medical medical_review\">&quot;Beta-lactam antibiotics: Mechanisms of action and resistance and adverse effects&quot;, section on 'Hematologic reactions'</a>.) </p><p class=\"headingAnchor\" id=\"H22930453\"><span class=\"h2\">Laboratory evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The coagulation abnormalities caused by vitamin K deficiency are manifested as prolonged prothrombin time (PT) and International Normalized Ratio (INR). When the deficiency is mild, only the PT may be prolonged, due to a predominant effect on factor VII. In severe vitamin K deficiency, both the PT and partial thromboplastin time (PTT) may be affected. Levels of PIVKA-II (Proteins induced in vitamin K absence) are more sensitive than PT in detecting vitamin K deficiency and may be helpful in monitoring patients with diseases predisposing to vitamin K deficiency. Vitamin K levels also can be measured directly but are impractical for clinical use. (See <a href=\"topic.htm?path=clinical-use-of-coagulation-tests#H4\" class=\"medical medical_review\">&quot;Clinical use of coagulation tests&quot;, section on 'Prothrombin time (PT) and INR'</a>.) </p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamin K is a fat-soluble vitamin, thus any cause of fat malabsorption may result in vitamin K deficiency. Fat malabsorption may be caused by disorders of bile or pancreatic secretion, or by extensive disease or resection of the intestinal mucosa. As examples, patients with the following conditions are at risk for fat-soluble vitamin deficiencies and usually require supplementation and monitoring, as discussed in the corresponding topic reviews:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cystic fibrosis. (See <a href=\"topic.htm?path=cystic-fibrosis-nutritional-issues#H18\" class=\"medical medical_review\">&quot;Cystic fibrosis: Nutritional issues&quot;, section on 'Vitamin K'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Primary biliary cholangitis. (See <a href=\"topic.htm?path=overview-of-the-treatment-of-primary-biliary-cholangitis-primary-biliary-cirrhosis#H4\" class=\"medical medical_review\">&quot;Overview of the treatment of primary biliary cholangitis (primary biliary cirrhosis)&quot;, section on 'Deficiencies of fat-soluble vitamins'</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Primary sclerosing cholangitis. (See <a href=\"topic.htm?path=primary-sclerosing-cholangitis-in-adults-clinical-manifestations-and-diagnosis#H57938404\" class=\"medical medical_review\">&quot;Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis&quot;, section on 'Steatorrhea and vitamin deficiency'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Biliary atresia (See <a href=\"topic.htm?path=biliary-atresia#H19844897\" class=\"medical medical_review\">&quot;Biliary atresia&quot;, section on 'Fat-soluble vitamin supplements'</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Familial intrahepatic cholestasis and other inherited disorders associated with cholestasis. (See <a href=\"topic.htm?path=inherited-disorders-associated-with-conjugated-hyperbilirubinemia\" class=\"medical medical_review\">&quot;Inherited disorders associated with conjugated hyperbilirubinemia&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intestinal diseases associated with malabsorption, such as active celiac disease, inflammatory bowel disease, or short bowel syndrome, may be associated with vitamin K deficiency. This is particularly true if the terminal ileum is involved because this can cause maldigestion of the fat-soluble vitamins by reducing the bile salt pool. (See <a href=\"topic.htm?path=pathogenesis-epidemiology-and-clinical-manifestations-of-celiac-disease-in-adults\" class=\"medical medical_review\">&quot;Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults&quot;</a> and <a href=\"topic.htm?path=nutrient-deficiencies-in-inflammatory-bowel-disease\" class=\"medical medical_review\">&quot;Nutrient deficiencies in inflammatory bowel disease&quot;</a> and <a href=\"topic.htm?path=chronic-complications-of-short-bowel-syndrome-in-children\" class=\"medical medical_review\">&quot;Chronic complications of short bowel syndrome in children&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Liver failure &ndash; Because the vitamin-K dependent coagulation factors are synthesized in the liver, severe parenchymal liver disease also may lead to deficiencies of these factors. In patients with severe liver disease and coagulation abnormalities, measurement of factors V and VII can help to distinguish between liver parenchymal dysfunction and vitamin K malabsorption. (See <a href=\"topic.htm?path=hemostatic-abnormalities-in-patients-with-liver-disease\" class=\"medical medical_review\">&quot;Hemostatic abnormalities in patients with liver disease&quot;</a>.) &#160;</p><p/><p>Medications that may contribute to <a href=\"topic.htm?path=vitamin-k-phytonadione-drug-information\" class=\"drug drug_general\">vitamin K</a> deficiency include antibiotics and high doses of vitamins E or A. Antibiotics can contribute to vitamin K deficiency by affecting intestinal bacteria, and also through direct effects on vitamin K activation in the liver. Most of the ingested vitamin K is absorbed in the distal small intestine. A number of microorganisms, which colonize the colon and distal ileum, synthesize absorbable vitamin K (vitamin K2, menaquinone). Many broad-spectrum antibiotics diminish this population of bacteria, limiting menaquinone production [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/11\" class=\"abstract_t\">11</a>]. Second and third generation cephalosporin antibiotics are associated with hypoprothrombinemia and have a weak coumarin-like effect in patients with low vitamin K stores [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/12\" class=\"abstract_t\">12</a>]. They cause vitamin K deficiency by inhibiting the function of vitamin K epoxide reductase enzyme in the liver, therefore impairing the recycling of vitamin K (<a href=\"image.htm?imageKey=HEME%2F61632\" class=\"graphic graphic_figure graphicRef61632 \">figure 2</a>) [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/12\" class=\"abstract_t\">12</a>].</p><p>Extremely high doses of <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> and A antagonize vitamin K [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/13\" class=\"abstract_t\">13</a>]. Hypervitaminosis A appears to reduce absorption of vitamin K, as suggested by the observation that the parenteral infusion of <a href=\"topic.htm?path=vitamin-a-drug-information\" class=\"drug drug_general\">vitamin A</a> (retinoic acid) does not increase the vitamin K requirement [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/14\" class=\"abstract_t\">14</a>]. Very high doses of vitamin E also cause vitamin K deficiency, but do not appear to affect absorption [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/15\" class=\"abstract_t\">15</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Vitamin K deficient bleeding in newborns and young infants</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamin K deficiency is common in the newborn, and if vitamin K is not replaced, the infant is at risk for vitamin K deficient bleeding (VKDB), previously known as hemorrhagic disease of the newborn. It is characterized by cutaneous bruising or bleeding from mucosal surfaces, the gastrointestinal tract, umbilicus or circumcision site, <span class=\"nowrap\">and/or</span> intracranial hemorrhage (ICH).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Early-onset VKDB develops within the first 24 hours of life, and is usually associated with maternal medications that block <a href=\"topic.htm?path=vitamin-k-phytonadione-drug-information\" class=\"drug drug_general\">vitamin K</a> action (eg, anticonvulsants). It is associated with ICH in about 25 percent of affected infants [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/16\" class=\"abstract_t\">16</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Classic VKDB develops between one and four weeks of life, and is largely prevented by administration of <a href=\"topic.htm?path=vitamin-k-phytonadione-drug-information\" class=\"drug drug_general\">vitamin K</a> at birth. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Late-onset VKDB typically develops between three weeks and eight months of age. There is a high frequency of ICH in affected infants (eg, 50 percent in some series), and associated central nervous system symptoms such as vomiting or seizures may be the primary presenting symptoms [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/17\" class=\"abstract_t\">17</a>]. Of note, late-onset VKDB and associated ICH appear to be increasing in the United States, and these cases are associated with the parental refusal of vitamin K prophylaxis at birth, followed by exclusive breast feeding [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/18-20\" class=\"abstract_t\">18-20</a>]. It can also be precipitated by fat malabsorption due to gastrointestinal or hepatobiliary disease, such as biliary atresia, in infants who are not given parenteral <a href=\"topic.htm?path=vitamin-k-phytonadione-drug-information\" class=\"drug drug_general\">vitamin K</a> prophylaxis at birth, or by coumarin poisoning [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/17,21\" class=\"abstract_t\">17,21</a>]. One study documented ICH due to VKDB in 21 Egyptian infants despite standard parenteral vitamin K prophylaxis at birth; risk factors included exclusive breast feeding, diarrhea, and antibiotic consumption [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/22\" class=\"abstract_t\">22</a>]. </p><p/><p>Newborn infants are at risk for vitamin K deficiency because their immature liver does not efficiently utilize vitamin K. In addition, they tend to have low vitamin K stores because of the low vitamin K content of breast milk, a sterile gut, and poor placental transfer of vitamin K [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/23\" class=\"abstract_t\">23</a>]. In infants, the plasma concentrations of all vitamin K dependent factors are about 20 percent of the adult values. Within a month after birth, the levels rise to within normal limits [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/24\" class=\"abstract_t\">24</a>]. The risk of developing VKDB is further increased by maternal ingestion during pregnancy of <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a> or other coumarin-like anticoagulants, certain antibiotics (ie, cephalosporins), and some anticonvulsants [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/23\" class=\"abstract_t\">23</a>]. </p><p>To prevent VKDB, the American Academy of Pediatrics recommends administration of parenteral <a href=\"topic.htm?path=vitamin-k-phytonadione-drug-information\" class=\"drug drug_general\">vitamin K</a> at birth, and supplementation of infant formulas with vitamin K [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/25\" class=\"abstract_t\">25</a>]. (See <a href=\"topic.htm?path=overview-of-the-routine-management-of-the-healthy-newborn-infant\" class=\"medical medical_review\">&quot;Overview of the routine management of the healthy newborn infant&quot;</a> and <a href=\"#H19\" class=\"local\">'Prevention of vitamin K deficient bleeding in newborns'</a> below.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">EXCESS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vitamin K toxicity is very rare, and a tolerable upper limit for consumption has not been defined (<a href=\"image.htm?imageKey=PEDS%2F81151\" class=\"graphic graphic_table graphicRef81151 \">table 4</a>). Menadione, a synthetic water-soluble form of vitamin K, can cause hemolytic anemia, hyperbilirubinemia, jaundice, and kernicterus in infants [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/26\" class=\"abstract_t\">26</a>]. Menadione has been used in premature or low-birth-weight newborns and it may precipitate kernicterus only in high doses [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/27\" class=\"abstract_t\">27</a>]. However, this form of vitamin K supplementation is not widely available.</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">REQUIREMENTS</span></p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Daily value</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The primary source of vitamin K in the diet is from leafy green vegetables (<a href=\"image.htm?imageKey=HEME%2F78708\" class=\"graphic graphic_table graphicRef78708 \">table 2</a>). The dietary requirement, expressed as adequate intake (AI) is 90 micrograms daily in women and 120 micrograms daily in men (<a href=\"image.htm?imageKey=PEDS%2F81151\" class=\"graphic graphic_table graphicRef81151 \">table 4</a>) [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/28\" class=\"abstract_t\">28</a>].</p><p class=\"headingAnchor\" id=\"H25044870\"><span class=\"h2\">Parenteral nutrition</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients on <a href=\"topic.htm?path=total-parenteral-nutrition-drug-information\" class=\"drug drug_general\">total parenteral nutrition</a> require vitamin K supplementation. Vitamin K is included in most brands of standard multivitamin mix added to the parenteral nutrition solution. A typical daily dose of adult injectable multivitamins for parenteral nutrition includes 150 mcg of vitamin K1 (phytonadione).&nbsp;For patients on <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a>, daily intake of 150 mcg of vitamin K1 has not been associated with a requirement for excessive doses of warfarin, or sub-therapeutic anticoagulation, as long as the anticoagulation regimen is appropriately monitored and doses are adjusted as needed. Nonetheless, for patients on warfarin, some providers select a brand of multivitamin mix that does not contain vitamin K (eg, MVI-12). </p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Interference with oral anticoagulant therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In a study of healthy subjects stably anticoagulated with the vitamin K antagonist (VKA) <a href=\"topic.htm?path=acenocoumarol-united-states-not-available-drug-information\" class=\"drug drug_general\">acenocoumarol</a>, use of food supplements providing up to 100 <span class=\"nowrap\">micrograms/day</span> of vitamin K1 did not significantly interfere with treatment [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/29\" class=\"abstract_t\">29</a>]. The threshold dose of vitamin K1 causing a statistically significant lowering of the INR in these subjects was 150 <span class=\"nowrap\">micrograms/day,</span> an amount easily exceeded following the ingestion of one-half cup of kale (<a href=\"image.htm?imageKey=HEME%2F78708\" class=\"graphic graphic_table graphicRef78708 \">table 2</a>).</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Treatment of coagulopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Depending upon the cause of deficiency, <a href=\"topic.htm?path=vitamin-k-phytonadione-drug-information\" class=\"drug drug_general\">vitamin K</a> can be administered in doses of one to 25 mg via oral, intramuscular, subcutaneous, or intravenous routes. When vitamin K deficiency occurs in patients who are also receiving coumarin-like anticoagulants, doses of vitamin K should be minimized in order to prevent refractoriness to further anticoagulation. (See <a href=\"topic.htm?path=management-of-warfarin-associated-bleeding-or-supratherapeutic-inr#H21790898\" class=\"medical medical_review\">&quot;Management of warfarin-associated bleeding or supratherapeutic INR&quot;, section on 'Vitamin K dose, route, formulation'</a>.)</p><p>Vitamin K status can be determined indirectly by measuring vitamin K-dependent factors (ie, prothrombin, factors VII, IX, X, or protein C). In patients who are vitamin K deficient, levels of these factors often are less than 50 percent of normal [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/23\" class=\"abstract_t\">23</a>]. Measurement of des-gamma-carboxyprothrombin (DCP) in plasma is another more sensitive way of determining vitamin K deficiency. In normal subjects, DCP is zero; it is elevated in vitamin K deficiency from whatever cause <span class=\"nowrap\">and/or</span> liver disease [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/30\" class=\"abstract_t\">30</a>].</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Prevention of vitamin K deficient bleeding in newborns</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is general consensus that all babies should receive <a href=\"topic.htm?path=vitamin-k-phytonadione-drug-information\" class=\"drug drug_general\">vitamin K</a>. Standard treatment is with vitamin K (0.5 to 1 mg IM) administered at birth. For healthy, exclusively breastfed, term infants, an alternative strategy may be oral vitamin K1 (2 mg orally with the first feed and at one, four, and eight weeks of age). However, oral supplements may be less effective in preventing late-onset vitamin K deficient bleeding in infants, and no approved oral preparation is available in the United States. (See <a href=\"topic.htm?path=overview-of-the-routine-management-of-the-healthy-newborn-infant\" class=\"medical medical_review\">&quot;Overview of the routine management of the healthy newborn infant&quot;</a>.)</p><p>Administration of a second &quot;booster&quot; dose of <a href=\"topic.htm?path=vitamin-k-phytonadione-drug-information\" class=\"drug drug_general\">vitamin K</a> to selected infants has been suggested as a possible approach to prevent intracranial hemorrhage (ICH) due to late-onset vitamin K deficient bleeding (VKDB). Further studies are needed to determine the efficacy of this approach and selection factors. (See <a href=\"#H13\" class=\"local\">'Vitamin K deficient bleeding in newborns and young infants'</a> above.) </p><p>The Adequate Intake for vitamin K, as defined by the Food and Nutrition Board is not increased for lactating mothers. However, one study suggests that exclusively breast-fed infants often have low plasma vitamin K concentrations, and that this can be prevented by supplementation of the mothers' diet with 5 mg of vitamin K1 (phylloquinone) throughout the first 12 weeks of life [<a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/31,32\" class=\"abstract_t\">31,32</a>]. No studies have evaluated whether maternal supplementation with vitamin K has any clinically important benefits.</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=warfarin-coumadin-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Warfarin (Coumadin) (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H915632\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dietary vitamin K1 (phylloquinone or phytonadione) is found in green vegetables like spinach and broccoli (<a href=\"image.htm?imageKey=HEME%2F78708\" class=\"graphic graphic_table graphicRef78708 \">table 2</a>). The dietary requirement, expressed as adequate intake (AI) is 90 micrograms daily in women and 120 micrograms daily in men (<a href=\"image.htm?imageKey=PEDS%2F81151\" class=\"graphic graphic_table graphicRef81151 \">table 4</a>). Gut micro-flora synthesizes vitamin K2 (menaquinones, including menatetrenone), which provides a portion of the dietary requirement of vitamin K. Vitamin K absorption requires intact pancreatic and biliary function and fat absorptive mechanisms. (See <a href=\"#H2\" class=\"local\">'Sources'</a> above and <a href=\"#H4\" class=\"local\">'Metabolism'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vitamin K is essential for activity of several carboxylase enzymes within the hepatic cells and therefore is necessary for the activation of coagulation factors VII, IX, X, and prothrombin. The natural anticoagulants proteins S and C also require vitamin K for their activity. (See <a href=\"#H5\" class=\"local\">'Actions'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Coumarin-like anticoagulants are similar in structure to vitamin K (<a href=\"image.htm?imageKey=HEME%2F66755\" class=\"graphic graphic_figure graphicRef66755 \">figure 1</a>) and interrupt the vitamin K dependent carboxylation cycle. Vitamin K administration is one of the methods used to reverse the effects of coumarin. Patients with severely impaired liver function do not respond well to vitamin K supplementation, and coumarin-induced coagulopathy is not as easily reversed. (See <a href=\"#H8\" class=\"local\">'Mechanism of action of the coumarin-like family'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vitamin K is a cofactor for some proteins involved in bone mineralization. Clinical trials have examined the use of vitamin K1 (phylloquinone) or vitamin K2 for the treatment of osteoporosis, with conflicting results. (See <a href=\"#H9\" class=\"local\">'Bone formation'</a> above and <a href=\"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women#H21\" class=\"medical medical_review\">&quot;Overview of the management of osteoporosis in postmenopausal women&quot;, section on 'Therapies not recommended'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical signs and symptoms of vitamin K deficiency include easy bruisability, mucosal bleeding, splinter hemorrhages, melena, hematuria, or any other manifestations of impaired coagulation. Vitamin K deficiency in an otherwise healthy adult is rare. Patients at risk for vitamin K deficiency include those on long-term broad-spectrum antibiotics or those with fat malabsorption for a variety of reasons, including disorders of bile or pancreatic secretion, or extensive disease or resection of the intestinal mucosa. (See <a href=\"#H12\" class=\"local\">'Causes'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vitamin K deficiency is common in the newborn because of immature liver function and low transfer of vitamin K through the placenta or breast milk. If vitamin K is not replaced, the infant is at risk for vitamin K deficient bleeding (VKDB), previously known as hemorrhagic disease of the newborn. This disorder is associated with cutaneous, gastrointestinal, and intracranial bleeding in neonates, typically developing within the first week of life. To prevent VKDB, standard treatment is with vitamin K1 (0.5 to 1 mg IM) administered at birth. (See <a href=\"#H13\" class=\"local\">'Vitamin K deficient bleeding in newborns and young infants'</a> above and <a href=\"#H19\" class=\"local\">'Prevention of vitamin K deficient bleeding in newborns'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vitamin K deficiency causes prolonged prothrombin time (PT) and International Normalized Ratio (INR). In more severe vitamin K deficiency, the partial thromboplastin time (PTT) also may be affected. Levels of PIVKA-II (proteins induced in vitamin K absence) are more sensitive than PT in detecting vitamin K deficiency and may be helpful in monitoring patients with diseases predisposing to vitamin K deficiency. (See <a href=\"#H22930453\" class=\"local\">'Laboratory evaluation'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/1\" class=\"nounderline abstract_t\">Dam H. The antihemorrhagic vitamin of the chick: Occurrence and chemical nature. Nature 1935; 135:652.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/2\" class=\"nounderline abstract_t\">Vermeer C, Schurgers LJ. A comprehensive review of vitamin K and vitamin K antagonists. Hematol Oncol Clin North Am 2000; 14:339.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/3\" class=\"nounderline abstract_t\">Dam H, Geiger A, Glavind J, et al. Olierung des vitamins K in hochgereinigter form. Helv Chim Acta 1939; 22:310.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/4\" class=\"nounderline abstract_t\">Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999; 93:1798.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Fat-soluble vitamins. In: Pediatric Nutrition, 7th ed, Kleinman RE, Greer FR (Eds), American Academy of Pediatrics, Elk Grove Village 2011. p.461.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/6\" class=\"nounderline abstract_t\">Shearer MJ. Vitamin K. Lancet 1995; 345:229.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/7\" class=\"nounderline abstract_t\">Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood 1990; 75:1753.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/8\" class=\"nounderline abstract_t\">Davie EW. Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost 1995; 74:1.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/9\" class=\"nounderline abstract_t\">Fair DS, Marlar RA, Levin EG. Human endothelial cells synthesize protein S. Blood 1986; 67:1168.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/10\" class=\"nounderline abstract_t\">Cushman M, Booth SL, Possidente CJ, et al. The association of vitamin K status with warfarin sensitivity at the onset of treatment. Br J Haematol 2001; 112:572.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/11\" class=\"nounderline abstract_t\">Hooper CA, Haney BB, Stone HH. Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole. Lancet 1980; 1:39.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/12\" class=\"nounderline abstract_t\">Shearer MJ, Bechtold H, Andrassy K, et al. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol 1988; 28:88.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/13\" class=\"nounderline abstract_t\">Light RF, Alscher RP, Frey CN. VITAMIN A TOXICITY AND HYPOPROTHROMBINEMIA. Science 1944; 100:225.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/14\" class=\"nounderline abstract_t\">Smith FR, Goodman DS. Vitamin A transport in human vitamin A toxicity. N Engl J Med 1976; 294:805.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/15\" class=\"nounderline abstract_t\">Bettger WJ, Jones JP, Olson RE. Effect of alpha-tocopherol and alpha-tocopherolquinone on vitamin K-dependent carboxylation in the rat. Fed Proc 1982; 41:344.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/16\" class=\"nounderline abstract_t\">Volpe JJ. Intracranial hemorrhage in early infancy--renewed importance of vitamin K deficiency. Pediatr Neurol 2014; 50:545.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/17\" class=\"nounderline abstract_t\">Miyasaka M, Nosaka S, Sakai H, et al. Vitamin K deficiency bleeding with intracranial hemorrhage: focus on secondary form. Emerg Radiol 2007; 14:323.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/18\" class=\"nounderline abstract_t\">Notes from the field: Late vitamin K deficiency bleeding in infants whose parents declined Vitamin K prophylaxis &mdash; Tennessee, 2013. MMWR Morb Mortal Wkly Rep 2013; 62:901.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/19\" class=\"nounderline abstract_t\">Schulte R, Jordan LC, Morad A, et al. Rise in late onset vitamin K deficiency bleeding in young infants because of omission or refusal of prophylaxis at birth. Pediatr Neurol 2014; 50:564.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/20\" class=\"nounderline abstract_t\">Shearer MJ. Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev 2009; 23:49.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/21\" class=\"nounderline abstract_t\">Carpenter SL, Abshire TC, Anderst JD, Section on Hematology/Oncology and Committee on Child Abuse and Neglect of the American Academy of Pediatrics. Evaluating for suspected child abuse: conditions that predispose to bleeding. Pediatrics 2013; 131:e1357.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/22\" class=\"nounderline abstract_t\">Elalfy MS, Elagouza IA, Ibrahim FA, et al. Intracranial haemorrhage is linked to late onset vitamin K deficiency in infants aged 2-24&nbsp;weeks. Acta Paediatr 2014; 103:e273.</a></li><li class=\"breakAll\">Olson R. Vitamin K. In: Modern Nutrition in Health and Disease, Shils M, Olson J, Shike M, et al (Eds), Lippincott, Philadelphia 2000. p.363.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/24\" class=\"nounderline abstract_t\">Motohara K, Endo F, Matsuda I. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns. Lancet 1985; 2:242.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/25\" class=\"nounderline abstract_t\">American Academy of Pediatrics. Committee statement, Committee on Nutrition. Vitamin K supplementation for infants receiving milk substitute infant formulas and for those with fat malabsorption. Pediatrics 1971; 48:483.</a></li><li class=\"breakAll\">McLaren  D. Clinical manifestations of human vitamin and mineral disorders. In: Modern Nutrition in Health and Disease, Shils M, Olson J, Shike M, et al (Eds), Lippincott, Philadelphia 2000. p.485.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/27\" class=\"nounderline abstract_t\">Chawla D, Deorari AK, Saxena R, et al. Vitamin K1 versus vitamin K3 for prevention of subclinical vitamin deficiency: a randomized controlled trial. Indian Pediatr 2007; 44:817.</a></li><li class=\"breakAll\">Food and Nutrition Board of the Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (2000). National Academies Press, Washington DC, 2000. p. 162-196 http://books.nap.edu/openbook.php?isbn=0309072794 (Accessed on February 20, 2018).</li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/29\" class=\"nounderline abstract_t\">Schurgers LJ, Shearer MJ, Hamuly&aacute;k K, et al. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 2004; 104:2682.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/30\" class=\"nounderline abstract_t\">Blanchard RA, Furie BC, Kruger SF, et al. Immunoassays of human prothrombin species which correlate with functional coagulant activities. J Lab Clin Med 1983; 101:242.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/31\" class=\"nounderline abstract_t\">Greer FR. Are breast-fed infants vitamin K deficient? Adv Exp Med Biol 2001; 501:391.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-vitamin-k/abstract/32\" class=\"nounderline abstract_t\">Greer FR, Marshall SP, Foley AL, Suttie JW. Improving the vitamin K status of breastfeeding infants with maternal vitamin K supplements. Pediatrics 1997; 99:88.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2624 Version 27.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H915632\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">SOURCES</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CHEMISTRY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">METABOLISM</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">ACTIONS</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">Coagulation pathway</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Antithrombotic effects of proteins C and S</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Mechanism of action of the coumarin-like family</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Bone formation</a></li></ul></li><li><a href=\"#H10\" id=\"outline-link-H10\">DEFICIENCY</a><ul><li><a href=\"#H11\" id=\"outline-link-H11\">Symptoms</a></li><li><a href=\"#H22930453\" id=\"outline-link-H22930453\">Laboratory evaluation</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Causes</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Vitamin K deficient bleeding in newborns and young infants</a></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">EXCESS</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">REQUIREMENTS</a><ul><li><a href=\"#H16\" id=\"outline-link-H16\">Daily value</a></li><li><a href=\"#H25044870\" id=\"outline-link-H25044870\">Parenteral nutrition</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">Interference with oral anticoagulant therapy</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">Treatment of coagulopathy</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Prevention of vitamin K deficient bleeding in newborns</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H424056764\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H915632\" id=\"outline-link-H915632\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/2624|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=HEME/66755\" class=\"graphic graphic_figure\">- Vitamin K and warfarin</a></li><li><a href=\"image.htm?imageKey=HEME/61632\" class=\"graphic graphic_figure\">- Vitamin K pathway</a></li></ul></li><li><div id=\"GAST/2624|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/63827\" class=\"graphic graphic_table\">- Clinical symptoms of selected vitamin deficiencies</a></li><li><a href=\"image.htm?imageKey=HEME/78708\" class=\"graphic graphic_table\">- Vitamin K foods</a></li><li><a href=\"image.htm?imageKey=HEME/60052\" class=\"graphic graphic_table\">- Known Gla-containing proteins</a></li><li><a href=\"image.htm?imageKey=PEDS/81151\" class=\"graphic graphic_table\">- Fat soluble vitamins Daily Recommended Intake</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=beta-lactam-antibiotics-mechanisms-of-action-and-resistance-and-adverse-effects\" class=\"medical medical_review\">Beta-lactam antibiotics: Mechanisms of action and resistance and adverse effects</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=biliary-atresia\" class=\"medical medical_review\">Biliary atresia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-complications-of-short-bowel-syndrome-in-children\" class=\"medical medical_review\">Chronic complications of short bowel syndrome in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-use-of-coagulation-tests\" class=\"medical medical_review\">Clinical use of coagulation tests</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cystic-fibrosis-nutritional-issues\" class=\"medical medical_review\">Cystic fibrosis: Nutritional issues</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hemostatic-abnormalities-in-patients-with-liver-disease\" class=\"medical medical_review\">Hemostatic abnormalities in patients with liver disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inherited-disorders-associated-with-conjugated-hyperbilirubinemia\" class=\"medical medical_review\">Inherited disorders associated with conjugated hyperbilirubinemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-warfarin-associated-bleeding-or-supratherapeutic-inr\" class=\"medical medical_review\">Management of warfarin-associated bleeding or supratherapeutic INR</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=normal-skeletal-development-and-regulation-of-bone-formation-and-resorption\" class=\"medical medical_review\">Normal skeletal development and regulation of bone formation and resorption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nutrient-deficiencies-in-inflammatory-bowel-disease\" class=\"medical medical_review\">Nutrient deficiencies in inflammatory bowel disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-dietary-trace-minerals\" class=\"medical medical_review\">Overview of dietary trace minerals</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women\" class=\"medical medical_review\">Overview of the management of osteoporosis in postmenopausal women</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-routine-management-of-the-healthy-newborn-infant\" class=\"medical medical_review\">Overview of the routine management of the healthy newborn infant</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-treatment-of-primary-biliary-cholangitis-primary-biliary-cirrhosis\" class=\"medical medical_review\">Overview of the treatment of primary biliary cholangitis (primary biliary cirrhosis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-vitamin-a\" class=\"medical medical_review\">Overview of vitamin A</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-vitamin-d\" class=\"medical medical_review\">Overview of vitamin D</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-vitamin-e\" class=\"medical medical_review\">Overview of vitamin E</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-water-soluble-vitamins\" class=\"medical medical_review\">Overview of water-soluble vitamins</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-epidemiology-and-clinical-manifestations-of-celiac-disease-in-adults\" class=\"medical medical_review\">Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=warfarin-coumadin-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Warfarin (Coumadin) (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-sclerosing-cholangitis-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=protein-c-deficiency\" class=\"medical medical_review\">Protein C deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=protein-s-deficiency\" class=\"medical medical_review\">Protein S deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vitamin-k-and-the-synthesis-and-function-of-gamma-carboxyglutamic-acid\" class=\"medical medical_review\">Vitamin K and the synthesis and function of gamma-carboxyglutamic acid</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vitamin-supplementation-in-disease-prevention\" class=\"medical medical_review\">Vitamin supplementation in disease prevention</a></li></ul></div></div>","javascript":null}